4//SEC Filing
Tung Roger D 4
Accession 0001209191-23-002556
CIK 0001367920other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:18 PM ET
Size
8.5 KB
Accession
0001209191-23-002556
Insider Transaction Report
Form 4
Tung Roger D
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2023-01-06$7.24/sh−9,240$66,898→ 971,018 total
Holdings
- 12,389(indirect: By Trust)
Common Stock
- 121,873(indirect: By Roger D. Tung 2011 GRAT)
Common Stock
- 13,274(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan entered into on June 23, 2022.
- [F2]These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.25 to $7.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F4]Shares held by Roger D. Tung 2011 GRAT. Dr. Tung is the sole trustee of the Roger D. Tung 2011 GRAT. Dr. Tung disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F5]Shares held by the Tung Family Investment Trust. Dr. Tung is a co-trustee of the Tung Family Investment Trust. Dr. Tung disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F6]Shares held by the RD Tung Irrevocable Trust. Dr. Tung's spouse is a co-trustee of the RD Tung Irrevocable Trust. Dr. Tung disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
Documents
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001594857
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:18 PM ET
- Size
- 8.5 KB